Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03907852
Title Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors TCR2 Therapeutics
Indications

peritoneal mesothelioma

cholangiocarcinoma

malignant pleural mesothelioma

ovary serous adenocarcinoma

lung non-small cell carcinoma

Therapies

Gavocabtagene autoleucel + Ipilimumab + Nivolumab

Gavocabtagene autoleucel + Nivolumab

Gavocabtagene autoleucel

Cyclophosphamide + Fludarabine

Age Groups: adult | senior
Covered Countries USA | CAN


No variant requirements are available.